Form 8-K - Current report:
SEC Accession No. 0001293971-21-000067
Filing Date
2021-09-07
Accepted
2021-09-07 16:09:15
Documents
13
Period of Report
2021-09-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blue-20210907.htm   iXBRL 8-K 37445
2 EX-99.1 exhibit99120210907.htm EX-99.1 19058
  Complete submission text file 0001293971-21-000067.txt   200703

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20210907.xsd EX-101.SCH 1923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20210907_lab.xml EX-101.LAB 24270
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20210907_pre.xml EX-101.PRE 12652
6 EXTRACTED XBRL INSTANCE DOCUMENT blue-20210907_htm.xml XML 11196
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02142
Business Address 60 BINNEY STREET CAMBRIDGE MA 02142 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 211239387
SIC: 2836 Biological Products, (No Diagnostic Substances)